Hepatitis C Testing Market Research Report 2022: Size, Segments, Share, Trends, Analysis, Regulatory & Reimbursement Landscape, Procedures & Forecasts, 2015-2030 – ResearchAndMarkets.com

Hepatitis C Testing Market Research Report 2022: Size, Segments, Share, Trends, Analysis, Regulatory & Reimbursement Landscape, Procedures & Forecasts, 2015-2030 – ResearchAndMarkets.com

DUBLIN – (COMMERCIAL LINE) – Report “Hepatitis C Tests Market Size (Value, Volume, ASP) by Segments, Stocks, Trends and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecasts, 2015-2030” has been added to by ResearchAndMarkets.com offer.

The model details the impact of COVID-19 on the hepatitis C test market for the year 2020 and beyond.

Hepatitis C is a viral infection caused by the hepatitis C virus (HCV). The hepatitis C virus is a blood-borne virus that causes liver disease and can cause acute and chronic hepatitis. Infection can be caused by the use of injection drugs, the transfusion of unscreened blood products, unsafe injection practices, sexual contact, and from the infected mother to her baby.

Diagnosis of HCV infection can be made by screening for antibodies to HCV along with a serological test to confirm viral infection. The HCV Ribonucleic Acid (RNA) Nucleic Acid Test is performed for positive HCV antibody test results to confirm chronic infection.

Because there is no vaccine available for HCV infection, the World Health Organization (WHO) recommends blood tests to screen patients who have an increased risk of HCV infection and to reduce the risk of HCV exposure. in health facilities. Screening of pregnant women for HCV is a standard of care in most countries and is considered a cost-effective strategy to reduce the risk of transmission to the baby.

Tests for hepatitis C virus include hepatitis C enzyme-linked immunosorbent assay / enzyme-linked immunosorbent assay (EIA / ELISA), hepatitis C nucleic acid amplification test (NAAT) and nucleic acid amplification test multiparameter hepatitis C (NAAT) HIV, hepatitis B and hepatitis C).

Each of the 39 countries covered full-source and color-coded market models come with epidemiology-based indications with volumes of procedures. To increase data transparency, Excel’s interactive deliverable covers installed base, new sales volumes, product usage, average sales prices, market size, and company share / ranking analysis (if available). Additionally, analyst comments with qualitative insights provide context for quantitative data.

Reasons to buy

  • Understand the impact of COVID-19 on the hepatitis C test market.

  • Develop and design your internal licensing and external licensing strategies by reviewing pipeline products and technologies and identifying companies with the strongest pipeline.

  • Develop business strategies by understanding the trends that shape and drive the hepatitis C test market.

  • Drive revenue by understanding key trends, innovative products and technologies, market segments and companies that could impact the hepatitis C testing market in the future.

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the business share of market leaders.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.

  • Track device sales in the global and country-specific hepatitis C test market from 2015 to 2030.

  • Organize your sales and marketing activities by identifying the categories and market segments that present the greatest opportunities for consolidations, investments and strategic partnerships.

The key inclusions of the market model are:

  • Currently commercialized hepatitis C tests and evolving competitive landscape

  • In-depth review of key industry trends.

  • Total annualized hepatitis C test market revenue by segment and market outlook from 2015 to 2030.

  • Market-level data on units, average selling prices and market values.

Market-specific insights at global, regional and national levels:

  • There is market specific qualitative information with global trends further broken down into regional trends. Additionally, analysts provide unique country-specific insights into the market.

  • SWOT Analysis for the Hepatitis C Test Market

  • Competitive Dynamics Insights & Trends Provided for the Hepatitis C Tests Market.

Drive understanding of the market by getting the real big picture, including an overview of the health system.

  • Country-specific overview of the health system.

  • Country specific refund policies.

  • Regulatory landscape for country-specific medical technologies.

Companies covered:

  • Abbott Laboratories

  • Siemens AG

  • Grifols SA

  • F. Hoffmann-La Roche Ltd

  • Ortho Clinical Diagnostics Holdings Plc

  • Hologic Inc

  • Oswaldo Cruz Foundation

  • Grifols SA

  • Qiagen NV

  • Dia Sorin SpA

For more information on this report, please visit https://www.researchandmarkets.com/r/nbke3l

Leave a Comment

Your email address will not be published.